Author

Lulu Zhang

Center for Excellence in Molecular Cell ScienceORCID 0000-0002-8284-5781Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Aifu LiniD· 1 shared Chenqi XuiD· 1 shared Chuanyang LiuiD· 1 shared Chune Yu· 1 shared Dun Li· 1 shared Ensi Ma· 1 shared Fangzhou LiuiD· 1 shared Feifei Zhang· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aifu LinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintOct 15, 2025

Cholesterol esterification blockade boosts immunotherapy and reduces liver cancer relapse

Yange Gu, Lulu Zhang, Jianhua Li…·Guangchuan Wang

This study identifies SOAT1 as a target for improving immunotherapy and reducing liver cancer relapse by blocking cholesterol esterification.

DOI 10.1101/2025.10.15.682531

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 13, 2025

C9orf50 is a Targetable Spliceosome Regulator for Cancer Immunotherapy

Tong Shao, Chuanyang Liu, Jingyu Kuang…·Lvyun Zhu

This study identifies C9orf50 as a spliceosome regulator that, when targeted, converts immunologically cold tumors to hot ones by enhancing immunogenicity and T cell recruitment.

DOI 10.1101/2025.03.13.642772

mousebulk RNA-seq

𝕏 PostBluesky